Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab
Jordi Monés, Sunil Srivastava, Glenn J. Jaffe, Ramin Tadayoni, Thomas A. Albini, Peter K. Kaiser, Frank G. Holz, Jean‐François Korobelnik, Ivana K. Kim, Christian Pruente, Timothy G. Murray, Jeffrey S. Heier
Topics & Concepts
MedicineRetinal vasculitisAfliberceptEndophthalmitisOphthalmologyMacular degenerationVasculitisFluorescein angiographyVisual acuityFundus (uterus)Branch retinal vein occlusionSurgeryBevacizumabMacular edemaInternal medicineChemotherapyDiseaseRetinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal and Optic Conditions